Skip to main content
. Author manuscript; available in PMC: 2020 Mar 15.
Published in final edited form as: Subst Abus. 2019 Mar 15;40(1):71–79. doi: 10.1080/08897077.2018.1546263

Table 2.

Demographic characteristics of patients with sampled International Classification of Diseases-9 Clinical Modification codes, by site (n=259)

Characteristics Site 1 (n=123a) Site 2 (n=126b) p-value

Age in years, 0.008c
 Mean (std dev) 46.4 (20.4) 40.3 (14.4)
 Median (25th, 75th percentile) 46.0 (24.0, 64.0) 37.0 (28.5, 51.0)

Gender, n (%) 0.002d
 Male 51 (41.5) 77 (61.1)
 Female 72 (58.5) 49 (38.9)

Race/ethnicity, n (%) <0.001d
 White 89 (72.4) 71 (56.4)
 Hispanic 8 (6.5) 37 (29.4)
 African American 7 (5.7) 16 (12.7)
 Other and Unknown 19 (15.4) 2 (1.6)

Insurance typee, n (%) <0.001d
 Commercial 74 (60.2) 8 (6.4)
 Medicaid 9 (7.3) 59 (46.8)
 Medicare 36 (29.3) 23 (18.3)
 Indigent Plan Care 0 6 (4.8)
 Others 4 (3.3) 19 (15.1)
 Unknown 0 11 (8.7)
a

7 patients had more than 1 event during the study period (total events=131)

b

2 patients had more than 1 event during the study period (total events=128)

c

Compared the difference in means using the t-test

d

Compared using the chi-square test

e

Patients with more than 1 event had the same insurance at all visits